Skip to main content
. Author manuscript; available in PMC: 2023 Jan 10.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):22–29. doi: 10.1158/1055-9965.EPI-22-0544

Figure 1.

Figure 1.

Published estimates of the decrease in CRC screening (panel A) and diagnosis (panel B) as a result of the COVID-19 pandemic identified by our literature search (2, 4, 26–36). The severity of disruption was determined by taking the average across all studies (solid line). From September 2020, the average decrease of the last three months with available data was used as severity of disruption for preventive services. The average ratio between preventive and diagnostic procedures from March 2020-September 2020 was used to set the severity of disruption for diagnostic procedures for the remaining months of the disruption period. EHRN = Epic Health Research Network